Homoarginine and Cardiovascular Outcome in the Population-Based Dallas Heart Study | Zendy

Dorothee Atzler | Zendy; M. Odette Gore | Zendy; Colby Ayers | Zendy; Chi-un Choe | Zendy; Rainer H. Böger | Zendy; James A. de Lemos | Zendy; Darren K. McGuire | Zendy; Edzard Schwedhelm | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Homoarginine and Cardiovascular Outcome in the Population-Based Dallas Heart Study

Author(s) -

Dorothee Atzler,

M. Odette Gore,

Colby Ayers,

Chi-un Choe,

Rainer H. Böger,

James A. de Lemos,

Darren K. McGuire,

Edzard Schwedhelm

Publication year - 2014

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.114.304398

Subject(s) - interquartile range , hazard ratio , subclinical infection , medicine , cardiology , confidence interval , population , proportional hazards model , coronary artery disease , environmental health

The nonproteinogenic amino acid homoarginine has been postulated to have antiatherosclerotic effects as a weak substrate of nitric oxide synthase. This investigation in the population-based Dallas Heart Study (DHS) aimed to evaluate the association of homoarginine with clinical and subclinical cardiovascular outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research